Livongo (formerly Retrofit) is digital healthcare company offering mobile, online and personalized, real-time support for people at risk for or living with chronic conditions.

Register for Details

For more details on financing and valuation of private companies similar to Livongo before its , register or login today.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn More About Livongo

To invest in Livongo pre-IPO

Can you invest in Livongo pre-IPO?

You may invest in Livongo as it is a public company listed on the NASDAQ with ticker LVGO. But if you are an accredited investor interested in buying pre-IPO shares of a private company, you can learn more about how to invest in the private market or register today to get started.

Can you sell shares of Livongo before it goes public?

You can no longer sell shares of Livongo on Forge as this company is no longer private. However, if you own shares of a private company, Forge may be able to help you sell them in a way that works for you and the company. Learn more or register with us today to get started.

What is the pre-IPO value of my Livongo shares?

Forge can no longer determine the value of Livongo shares as this company is no longer private. However, if you own shares of a private company, Forge may help you value and sell them in a way that works for you and the company. Learn more or register with us today to get started.

Is Livongo a publicly traded company?

Livongo became a public company following its IPO on 07/25/2019 and is now traded on the NASDAQ under the ticker LVGO.

To learn more about Livongo potential IPO

Will Livongo go IPO?

Livongo became a public company following its IPO on 07/25/2019 and is now traded on the NASDAQ under the ticker LVGO.

What is Livongo’s IPO price?

The IPO price of Livongo is not currently available.

When was Livongo founded?

Livongo was founded in 2007.

What is Livongo funding to date?

Livongo has raised $237.65MM to date.

Livongo Funding Rounds and Valuation

Funding History Chart
Funding Round Details
Funding Date Share Class Amount Raised Price per Share Post-Money Valuation Key Investors
04/23/2018 Series E $105MM $xx.xx $796.49MM 7wire Ventures, Echo Health Ventures, General Catalyst, Global Health Innovation Fund, Kinnevikmerck, Kleiner Perkins & Draper Fisher Jurvetson Management, M12, Sapphire Ventures, Wanxiang America, Zaffre Investments
Price per Share
$xx.xx
Shares Outstanding
12,655,481
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
7wire Ventures, Echo Health Ventures, General Catalyst, Global Health Innovation Fund, Kinnevikmerck, Kleiner Perkins & Draper Fisher Jurvetson Management, M12, Sapphire Ventures, Wanxiang America, Zaffre Investments
03/16/2017 Series D $52.5MM $xx.xx $320MM American Investment Holdings, Edb Investments, General Catalyst Partners & Kinnevik, Kleiner Perkins Caufield & Byers, Microsoft Ventures & Undisclosed Existing Investors, Singapore Economic Development Board
Price per Share
$xx.xx
Shares Outstanding
11,773,937
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
American Investment Holdings, Edb Investments, General Catalyst Partners & Kinnevik, Kleiner Perkins Caufield & Byers, Microsoft Ventures & Undisclosed Existing Investors, Singapore Economic Development Board
04/22/2016 Series C $49.5MM $xx.xx $194MM Cowen Private Investments, Dfj & 7wire Ventures, General Catalyst, Glen Tullman, Healthcare Growth Partners, Kleiner Perkins Caufield & Byers, Merck Global Health Innovation Fund, Sapphire Ventures, Wanxiang America Corporation, Zaffre Investments
Price per Share
$xx.xx
Shares Outstanding
14,856,832
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Cowen Private Investments, Dfj & 7wire Ventures, General Catalyst, Glen Tullman, Healthcare Growth Partners, Kleiner Perkins Caufield & Byers, Merck Global Health Innovation Fund, Sapphire Ventures, Wanxiang America Corporation, Zaffre Investments
04/09/2015 Series B $20MM $xx.xx $87MM Draper Fisher Jurvetson & General Catalyst Partner, Kleiner Perkins Caufield & Byers
Price per Share
$xx.xx
Shares Outstanding
8,934,953
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Draper Fisher Jurvetson & General Catalyst Partner, Kleiner Perkins Caufield & Byers
05/22/2007 Series A $10.65MM $xx.xx $30MM General Catalyst Partners & Slow Ventures
Price per Share
$xx.xx
Shares Outstanding
10,394,306
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
General Catalyst Partners & Slow Ventures
Updated on: Dec 1, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.